Clin2
NCT05984745Possibly a fitRecruiting

CoQ10 for fatty liver linked to metabolic issues

Fatty LiverNAFLD

Part of Digestive system clinical trials.

This study tests if CoQ10 (a natural supplement) can improve liver health in people with metabolic dysfunction-associated fatty liver disease (MAFLD). It may help if you have a fatty liver and related metabolic issues like high blood pressure or diabetes.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
60 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have at least 3 signs of metabolic problems (like high waist size, high blood sugar, or high blood pressure)
  • You have a fatty liver confirmed by imaging (like an ultrasound)
  • Your liver enzymes are slightly to moderately high (1 to 4 times normal)
  • You are not pregnant, not breastfeeding, and do not have other liver diseases or certain medical conditions

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07310407Not yet recruiting· Phase 2
Rutin and Vitamin C for Fatty Liver Disease

This study tests whether a combination of rutin (a plant compound) and vitamin C can help people with fatty liver disease (MASLD). If you have MASLD and no other serious liver conditions, this trial may be a good fit.

Cairo
NCT05930093Recruiting
Test LivPhcD capsules for fatty liver disease safety

This trial studies whether LivPhcD capsules can improve fatty liver disease and checks for side effects. It may help people with non-alcohol-related fatty liver disease who meet specific liver-scanning and lab results.

Taipei, Not Required For This Country
NCT04036357Recruiting
Study of liver fat disease with heart and metabolism problems

This study looks at people with fatty liver disease and common health issues like obesity, diabetes, high blood pressure, or abnormal cholesterol. It may help researchers understand how liver fat and heart/metabolism problems relate and how they affect health over time.

Rome
NCT07740109Not yet recruiting
Folate supplement for fatty liver disease

This trial tests whether a form of folic acid (5-methyltetrahydrofolate) can help people with fatty liver disease. It may improve liver health by supporting fat and sugar processing.

Tabriz
NCT07748130Not yet recruiting
Coenzyme Q10 for liver fat in mitochondrial diabetes

This study tests whether coenzyme Q10, a natural supplement, can reduce fat in the liver for people with mitochondrial diabetes, a rare form of diabetes caused by a specific gene change. If you have this condition, the study aims to see if the supplement improves liver health.

Putian, Fujian
NCT06506630Recruiting
Coenzyme Q10 for metabolic syndrome risk

This trial tests whether taking Coenzyme Q10, a natural supplement, can improve heart health markers in people who have or are at high risk for metabolic syndrome. Metabolic syndrome is a group of conditions like high blood sugar, high blood pressure, and belly fat that raise your risk for heart disease and diabetes.

Shenzhen

Hear when a new Fatty Liver trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.